All Stories

  1. European Aedes albopictus and Culex pipiens Are Competent Vectors for Japanese Encephalitis Virus
  2. Zika rash and increased risk of congenital brain abnormalities
  3. Zika virus: epidemiology, clinical features and host-virus interactions
  4. The South Pacific epidemic strain of Zika virus replicates efficiently in human epithelial A549 cells leading to IFN-β production and apoptosis induction
  5. The E glycoprotein plays an essential role in the high pathogenicity of European–Mediterranean IS98 strain of West Nile virus
  6. Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study
  7. Comparative analysis of viral RNA signatures on different RIG-I-like receptors
  8. A Single Amino Acid Substitution in the M Protein Attenuates Japanese Encephalitis Virus in Mammalian Hosts
  9. Tackling dengue fever: Current status and challenges
  10. Seroprevalence of arboviruses among blood donors in French Polynesia, 2011–2013
  11. Neutralization of Japanese Encephalitis Virus by heme-induced broadly reactive human monoclonal antibody
  12. A Lentiviral Vector Expressing Japanese Encephalitis Virus-like Particles Elicits Broad Neutralizing Antibody Response in Pigs
  13. Silent Circulation of Ross River Virus in French Polynesia
  14. Biology of Zika Virus Infection in Human Skin Cells
  15. Inflammasome signaling pathways exert antiviral effect against Chikungunya virus in human dermal fibroblasts
  16. Rapid Uptake and Inhibition of Viral Propagation by Extracellular OAS1
  17. Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial
  18. A Japanese Encephalitis Virus Genotype 5 Molecular Clone Is Highly Neuropathogenic in a Mouse Model: Impact of the Structural Protein Region on Virulence
  19. Human keratinocytes restrict chikungunya virus replication at a post-fusion step
  20. Recognition determinants of broadly neutralizing human antibodies against dengue viruses
  21. Role of skin immune cells on the host susceptibility to mosquito-borne viruses
  22. High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
  23. Rift Valley Fever in Humans and Animals in Mayotte, an Endemic Situation?
  24. A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus
  25. Dengue Virus Activates Membrane TRAIL Relocalization and IFN-α Production by Human Plasmacytoid Dendritic Cells In Vitro and In Vivo
  26. The E2-E166K substitution restores Chikungunya virus growth in OAS3 expressing cells by acting on viral entry
  27. IS-98-ST1 West Nile Virus Derived from an Infectious cDNA Clone Retains Neuroinvasiveness and Neurovirulence Properties of the Original Virus
  28. PS2-008. Mapping the active site and investigating the polyI:C inducibility of the human 120 kDa 2’-5’ Oligoadenylate Synthetase 3
  29. Dengue virus replication in infected human keratinocytes leads to activation of antiviral innate immune responses
  30. The interaction of flavivirus M protein with light chain Tctex-1 of human dynein plays a role in late stages of virus replication
  31. Transgenic expression of full-length 2′,5′-oligoadenylate synthetase 1b confers to BALB/c mice resistance against West Nile virus-induced encephalitis
  32. Chikungunya Virus, Southeastern France
  33. SS10-7 The battle between host and virus: how chikungunya virus is inhibited by 2′-5′-oligoadenylate synthetases and how it may escape the battle
  34. Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses
  35. West Nile virus and its emergence in the United States of America
  36. Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2′,5′-oligoadenylate synthetase 1b
  37. DNA vaccines expressing retrovirus-like particles are efficient immunogens to induce neutralizing antibodies
  38. The large form of human 2′,5′-Oligoadenylate Synthetase (OAS3) exerts antiviral effect against Chikungunya virus
  39. Human genetic determinants of dengue virus susceptibility
  40. Protective Antiviral Immunity Conferred by a Nonintegrative Lentiviral Vector-Based Vaccine
  41. Inhibition of Chikungunya Virus Infection in Cultured Human Muscle Cells by Furin Inhibitors
  42. Production and characterization of mouse monoclonal antibodies reactive to Chikungunya envelope E2 glycoprotein
  43. A Mouse Model for Chikungunya: Young Age and Inefficient Type-I Interferon Signaling Are Risk Factors for Severe Disease
  44. Pediatric Measles Vaccine Expressing a Dengue Antigen Induces Durable Serotype-specific Neutralizing Antibodies to Dengue Virus
  45. Two Chikungunya Isolates from the Outbreak of La Reunion (Indian Ocean) Exhibit Different Patterns of Infection in the Mosquito, Aedes albopictus
  46. Human Muscle Satellite Cells as Targets of Chikungunya Virus Infection
  47. Characterization of Reemerging Chikungunya Virus
  48. Comparative mechanistic studies of de novo RNA synthesis by flavivirus RNA-dependent RNA polymerases
  49. Genome Microevolution of Chikungunya Viruses Causing the Indian Ocean Outbreak
  50. A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus
  51. Association d’un variant génétique du récepteur d’attachement DC-SIGN (CD209) à la gravité de la dengue
  52. Innate Immune Responses to Dengue Virus
  53. A Paediatric Vaccination Vector Based on Live Attenuated Measles Vaccine
  54. Dendritic Cell-specific Intercellular Adhesion Molecule 3-grabbing Non-integrin (DC-SIGN)-mediated Enhancement of Dengue Virus Infection Is Independent of DC-SIGN Internalization Signals
  55. A variant in the CD209 promoter is associated with severity of dengue disease
  56. Live Measles Vaccine Expressing the Secreted Form of the West Nile Virus Envelope Glycoprotein Protects against West Nile Virus Encephalitis
  57. New insights on the neuropathogenicity of West Nile virus
  58. Structural and functional genomics and evolutionary relationships in the cluster of genes encoding murine 2′,5′-oligoadenylate synthetases
  59. Expression of dengue ApoptoM sequence results in disruption of mitochondrial potential and caspase activation
  60. Dendritic‐cell‐specific ICAM3‐grabbing non‐integrin is essential for the productive infection of human dendritic cells by mosquito‐cell‐derived dengue viruses
  61. Infection of mouse neurones by West Nile virus is modulated by the interferon-inducible 2'-5' oligoadenylate synthetase 1b protein
  62. Mechanisms of Dengue virus-induced cell death
  63. Les gènesOASet la sensibilité au virus du Nil occidental
  64. Genome analysis of dengue type-1 virus isolated between 1990 and 2001 in Brazil reveals a remarkable conservation of the structural proteins but amino acid differences in the non-structural proteins
  65. La dengue
  66. Determinants in the Envelope E Protein and Viral RNA Helicase NS3 That Influence the Induction of Apoptosis in Response to Infection with Dengue Type 1 Virus
  67. Apoptotic cell death in response to dengue virus infection: the pathogenesis of dengue haemorrhagic fever revisited
  68. Les flavivirus responsables de fièvres hémorragiques
  69. The role of antibody in recovery from alphavirus encephalitis
  70. Differences between Cell Membrane Fusion Activities of Two Dengue Type-1 Isolates Reflect Modifications of Viral Structure